Your browser doesn't support javascript.
loading
Using Esterase Selectivity to Determine the In Vivo Duration of Systemic Availability and Abolish Systemic Side Effects of Topical ß-Blockers.
Baker, Jillian G; Fromont, Christophe; Bruder, Marjorie; Thompson, Kevin S J; Kellam, Barrie; Hill, Stephen J; Gardiner, Sheila M; Fischer, Peter M.
Afiliação
  • Baker JG; Cell Signalling Research Group, Division of Physiology, Pharmacology and Neuroscience, School of Life Sciences, University of Nottingham, Nottingham, NG7 2RD, U.K.
  • Fromont C; Centre of Membrane Proteins and Receptors, University of Birmingham and University of Nottingham, The Midlands, U.K.
  • Bruder M; School of Pharmacy and Centre for Biomedical Sciences, University of Nottingham, Nottingham, NG7 2RD, U.K.
  • Thompson KSJ; Centre of Membrane Proteins and Receptors, University of Birmingham and University of Nottingham, The Midlands, U.K.
  • Kellam B; Cell Signalling Research Group, Division of Physiology, Pharmacology and Neuroscience, School of Life Sciences, University of Nottingham, Nottingham, NG7 2RD, U.K.
  • Hill SJ; Centre of Membrane Proteins and Receptors, University of Birmingham and University of Nottingham, The Midlands, U.K.
  • Gardiner SM; School of Pharmacy and Centre for Biomedical Sciences, University of Nottingham, Nottingham, NG7 2RD, U.K.
  • Fischer PM; Cell Signalling Research Group, Division of Physiology, Pharmacology and Neuroscience, School of Life Sciences, University of Nottingham, Nottingham, NG7 2RD, U.K.
ACS Pharmacol Transl Sci ; 3(4): 737-748, 2020 Aug 14.
Article em En | MEDLINE | ID: mdl-32832874

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2020 Tipo de documento: Article